ArticleScientific reports2025
Early functional network alterations predict motor and cognitive decline in parkinson's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bidirectional Mechanisms Linking Circadian Rhythm Disruption and Parkinson's Disease: Chronobiomarkers and Therapeutic Implications.International journal of molecular sciences · 2026Review
- Iron accumulation in the substantia nigra is linked to functional network connectivity alterations in early-stage Parkinson's Disease: an exploratory study.NPJ Parkinson's disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify potential structural and resting state FC (rs-FC) alterations in de novo PD and examine their possible relationship with motor and cognitive symptoms; and to explore whether early structural and rs-FC alterations were associated with subsequent clinical progression. Seventy-eight de novo PD patients and thirty-one healthy subjects (HS) were enrolled. The severity of motor symptoms was assessed by the MDS-Unified Parkinson’s Disease rating scale and cognitive performance was assessed with the Montreal Cognitive Assessment. Forty out of 78 PD patients underwent a clinical follow-up after a period of 5.29 ± 1.40 years. All participants underwent 3T MRI scanning. Structural MRI analyses included gray matter volume estimation, thalamus, basal ganglia and cerebellar volumetry. Resting-state functional connectivity was assessed using independent component analysis. Compared to HS, de novo PD patients did not show any structural alteration. Conversely, they showed decreased rs-FC in several brain networks, including the default mode network, sensorimotor, cerebellar, medial visual, occipital, orbitofrontal, dorsal attention, executive control, and the left frontoparietal networks. Although baseline functional alterations were not associated with clinical measures at the time of assessment, reduced baseline rs-FC in most resting-state networks was predictive of clinical progression over time. De novo PD patients exhibit widespread rs-FC alterations across multiple brain networks, despite a preserved structural integrity. Early rs-FC alterations in sensorimotor, cerebellar, and cognitive networks were linked to subsequent clinical deterioration. These findings highlight the potential of rs-fMRI as a valuable early imaging correlate for tracking disease progression in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.